Translational Development Acquisition Corp. (TDAC) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-27 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-07-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-23 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-18 | 8-K | Material Agreement, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-06-12 | 8-K | Unregistered Sales | SEC |
| 2026-05-27 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-14 | 8-K | Direct Financial Obligation, Other Events, Financial Statements & Exhibits | SEC |
| 2025-02-14 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-31 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-27 | 8-K | Material Agreement, Unregistered Sales, Officer / Director Changes, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.